Reese David M (CIK 0001748434)

Latest company ownership

Role: EVP & Chief Technology Officer
Shares held
35,503
Last filed at
Nov 12, 2025
Confidence Score
47.1
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 2, 2025 May 6, 2025 AMGEN INC EVP & Chief Technology Officer Sell 20.0 -1,367 -3.42% $387.9K
Apr 30, 2025 May 2, 2025 AMGEN INC EVP & Chief Technology Officer Sell 22.5 -768 -1.89% $221.6K
Mar 17, 2025 Mar 19, 2025 AMGEN INC EVP & Chief Technology Officer Sell 17.5 -3,635 -8.20% $1.1M
Feb 19, 2025 Feb 21, 2025 AMGEN INC EVP & Chief Technology Officer Sell 15.0 -33,936 -47.89% $10.2M
May 5, 2024 May 7, 2024 AMGEN INC EVP & Chief Technology Officer Sell 22.5 -633 -1.07% $197K
May 2, 2024 May 3, 2024 AMGEN INC EVP & Chief Technology Officer Sell 22.5 -650 -1.08% $180.3K
Apr 30, 2024 May 1, 2024 AMGEN INC EVP & Chief Technology Officer Sell 22.5 -690 -1.14% $190.7K
Mar 18, 2024 Mar 20, 2024 AMGEN INC EVP & Chief Technology Officer Sell 17.5 -6,202 -9.27% $1.7M
May 5, 2023 May 9, 2023 AMGEN INC EVP, Research and Development Sell 22.5 -594 -1.09% $137.7K
May 2, 2023 May 4, 2023 AMGEN INC EVP, Research and Development Sell 90.0 +2,995 5.79% $193.3K
Apr 30, 2023 May 2, 2023 AMGEN INC EVP, Research and Development Sell 22.5 -666 -1.27% $159.7K
Mar 17, 2023 Mar 20, 2023 AMGEN INC EVP, Research and Development Sell 20.0 -3,978 -7.06% $933.1K
Nov 2, 2022 Nov 3, 2022 AMGEN INC EVP, Research and Development Sell 40.0 -2,440 -4.82% $663.8K
May 5, 2022 May 9, 2022 AMGEN INC EVP, Research and Development Sell 22.5 -575 -1.13% $135.8K
May 2, 2022 May 4, 2022 AMGEN INC EVP, Research and Development Sell 90.0 +3,127 6.55% $177.8K
Apr 27, 2022 Apr 29, 2022 AMGEN INC EVP, Research and Development Sell 43.8 -184 -0.38% $46K
Mar 18, 2022 Mar 22, 2022 AMGEN INC EVP, Research and Development Sell 17.5 -4,995 -9.44% $1.2M
Nov 2, 2021 Nov 3, 2021 AMGEN INC EVP, Research and Development Sell 20.0 -2,192 -4.89% $459.8K
Apr 30, 2021 May 4, 2021 AMGEN INC EVP, Research and Development Sell 92.5 +2,152 5.09% $444.3K
Apr 27, 2021 Apr 28, 2021 AMGEN INC EVP, Research and Development Sell 43.8 -174 -0.41% $44.5K
Mar 19, 2021 Mar 22, 2021 AMGEN INC EVP, Research and Development Sell 20.0 -1,401 -3.19% $342.4K
Feb 16, 2021 Feb 16, 2021 AMGEN INC EVP, Research and Development Sell 40.0 -1,147 -2.73% $272.1K
Nov 2, 2020 Nov 4, 2020 AMGEN INC EVP, Research and Development Sell 20.0 -2,125 -5.09% $461K
May 1, 2020 May 5, 2020 AMGEN INC EVP, Research and Development Sell 20.0 -1,231 -3.14% $293K
Apr 27, 2020 Apr 29, 2020 AMGEN INC EVP, Research and Development Sell 43.8 -168 -0.43% $39.7K
Mar 20, 2020 Mar 24, 2020 AMGEN INC EVP, Research and Development Sell 20.0 -1,855 -4.50% $368.7K
Mar 9, 2020 Mar 10, 2020 AMGEN INC EVP, Research and Development Sell 42.5 -780 -1.87% $164.3K
May 3, 2019 May 7, 2019 AMGEN INC EVP, Research and Development Sell 91.3 +4,337 13.67% $30.7K
May 1, 2019 May 3, 2019 AMGEN INC EVP, Research and Development Sell 22.5 -1,014 -1.55% $181.8K
Mar 22, 2019 Mar 25, 2019 AMGEN INC EVP, Research and Development Sell 20.0 -1,769 -5.12% $339.5K
Jan 30, 2019 Feb 1, 2019 AMGEN INC EVP, Research and Development Sell 43.8 -115 -0.37% $22.1K